SCHEMBL10200220

SCHEMBL10200220

CCCN(Cc1nc2cc(I)ccc2[nH]1)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 1/20 0.39
CACNA1B Q00975 1/20 0.39
CACNA1C Q13936 1/20 0.39
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
PRKCZ Q05513 2/20 0.36
SSTR4 P31391 1/20 0.34
HDAC1 Q13547 3/20 0.34
TDP1 Q9NUW8 1/20 0.34
HDAC3 O15379 2/20 0.34
HDAC2 Q92769 2/20 0.34
NCOR2 Q9Y618 2/20 0.34
ALDH1A1 P00352 3/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10201483 0.87 CACNA1G (0.39) CACNA1GCACNA1BCACNA1CSSTR4HDAC1
SCHEMBL10202452 0.85 GABRA1 (0.41) CACNA1GCACNA1BCACNA1CGABRA1GABRG2
SCHEMBL19339591 0.81 HDAC3 (0.43) CACNA1GCACNA1BCACNA1CSSTR4HDAC1
SCHEMBL19488323 0.80 NPSR1 (0.51) CACNA1GCACNA1BCACNA1CTDP1ALDH1A1
SCHEMBL19339742 0.78 GABRA1 (0.39) CACNA1GCACNA1BCACNA1CGABRA1GABRG2
SCHEMBL19488867 0.78 KDM4E (0.48) HDAC1HDAC3HDAC2NCOR2ALDH1A1
SCHEMBL19488634 0.78 NPSR1 (0.38) CACNA1GCACNA1BCACNA1CHDAC1HDAC3
SCHEMBL19488842 0.78 NPSR1 (0.38) CACNA1GCACNA1BCACNA1CHDAC1HDAC3
SCHEMBL19488495 0.75 GABRA1 (0.33) CACNA1GCACNA1BCACNA1CGABRA1GABRG2
SCHEMBL12684222 0.74 ITGB3 (0.33) CACNA1GCACNA1BCACNA1CHDAC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018325-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-09 WO disclosed